YieldMax MRNA Option Income Strategy ETF (MRNY) Dividend Yield, History & Forecast

YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 45.07% ($18.83 per share annually (TTM)). The most recent ex-dividend date was October 29, 2026, with payment scheduled for October 30, 2026. market capitalization is approximately $302M. Review MRNY dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

MRNY fund composition

MRNY holds 7 positions. It charges an expense ratio of 1.00%, and manages $237.8M.

Sector allocation

Cash & Others100.0%

Compare MRNY

Yield, fees, returns and holdings overlap, side by side.

Frequently Asked Questions about YieldMax MRNA Option Income Strategy ETF (MRNY)

What is YieldMax MRNA Option Income Strategy ETF's dividend yield?
YieldMax MRNA Option Income Strategy ETF (MRNY) pays a current trailing twelve-month dividend yield of 45.07%, which works out to $18.83 per share annually based on the most recent payout schedule.
When does YieldMax MRNA Option Income Strategy ETF pay distributions?
The most recent ex-dividend date was October 29, 2026. The next scheduled dividend payment date is October 30, 2026.
What does YieldMax MRNA Option Income Strategy ETF invest in?
This actively managed exchange-traded fund, known as the YieldMax MRNA Option Income Strategy ETF (MRNY), is engineered to deliver consistent weekly income. It achieves this by strategically issuing call options or initiating call spreads that are tied to shares of MRNA. The fundamental design of this approach is to collect premiums from these options, while also providing investors with a means to participate in any upward movement in MRNA's stock valuation.